Abstract:Background-The definition, prevalence, outcomes, and appropriate treatment strategies for acute intramural hematoma (IMH) continue to be debated. Methods and Results-We studied 1010 patients with acute aortic syndromes who were enrolled in the International Registry of Aortic Dissection (IRAD) to delineate the prevalence, presentation, management, and outcomes of acute IMH by comparing these patients with those with classic aortic dissection (AD). Fifty-eight (5.7%) patients had IMH, and this cohort tended to … Show more
“…6 IMH may be related to PAU, accounting for 5e20% of patients with AAS and more commonly involving the DTA (60%) than the ascending aorta. 7 Trauma is the leading cause of death during the first four decades of life, accounting for more than 250,000 deaths every year in the European Union alone. 8 Blunt aortic injury is the second leading cause of death in these patients, and although it occurs in less than 1% of all motor vehicle accidents, it accounts for 16% of all traumatic deaths.…”
Section: Epidemiology Of Descending Thoracic Aortic Diseasementioning
confidence: 99%
“…119 The natural history of type B IMH is similar to that of ATBAD. 7,51 Conservative medical treatment is used for isolated uncomplicated type B IMH. 120 Treatment with bblockers has a survival rate of 95%, compared with 67% for those treated without b-blockade.…”
General rightsThis document is made available in accordance with publisher policies. Please cite only the published version using the reference above. Full terms of use are available:
“…6 IMH may be related to PAU, accounting for 5e20% of patients with AAS and more commonly involving the DTA (60%) than the ascending aorta. 7 Trauma is the leading cause of death during the first four decades of life, accounting for more than 250,000 deaths every year in the European Union alone. 8 Blunt aortic injury is the second leading cause of death in these patients, and although it occurs in less than 1% of all motor vehicle accidents, it accounts for 16% of all traumatic deaths.…”
Section: Epidemiology Of Descending Thoracic Aortic Diseasementioning
confidence: 99%
“…119 The natural history of type B IMH is similar to that of ATBAD. 7,51 Conservative medical treatment is used for isolated uncomplicated type B IMH. 120 Treatment with bblockers has a survival rate of 95%, compared with 67% for those treated without b-blockade.…”
General rightsThis document is made available in accordance with publisher policies. Please cite only the published version using the reference above. Full terms of use are available:
“…The majority of intramural hematomas occur in the descending aorta. Patients with intramural hematoma are usually older and more hypertensive than patients with classic acute aortic dissection (1,2). The hematoma can be focal or can extend proximally and distally.…”
Section: Differential Aspects Of the Diseasementioning
Acute type A aortic dissection is a deadly disease with significant morbidity and mortality. We describe the differential aspects of the disease and the North American experience with its treatment.
“…Die A. descendens ist in etwa 60 % der Fälle betroffen, bei Lokalisation des IMH im Bereich der A. ascendens ist wie bei der Typ-A-AD die Mortalität erhöht [14]. [23].…”
Das akute Aortensyndrom (AAS) ist zwar seltener, aber nicht weniger bedrohlich als die beiden anderen wichtigen Ursachen des akuten Thoraxschmerzes. Bei vier von fünf Patienten mit AAS liegt eine klassische Aortendissektion zugrunde; transmurale Hämatome oder penetrierende atheromatöse Ulzera kommen ebenfalls vor. Auch in diesen Fällen gilt es, rasch die Symptome und Befunde richtig einzuordnen und die -meist operative -Therapie zu initiieren.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.